Insider Selling: Arteris, Inc. (NASDAQ:AIP) Director Sells 2,776 Shares of Stock

Arteris, Inc. (NASDAQ:AIP) Director Saiyed Atiq Raza sold 2,776 shares of the firm’s stock in a transaction dated Monday, January 6th. The shares were sold at an average price of $12.34, for a total transaction of $34,255.84. Following the completion of the transaction, the director now directly owns 684,320 shares in the company, valued at approximately $8,444,508.80. The trade was a 0.40 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Saiyed Atiq Raza also recently made the following trade(s):

• On Thursday, December 26th, Saiyed Atiq Raza sold 41,439 shares of Arteris stock. The stock was sold at an average price of $10.37, for a total value of $429,722.43.
• On Wednesday, December 18th, Saiyed Atiq Raza sold 12,166 shares of Arteris stock. The shares were sold at an average price of $10.07, for a total value of $122,511.62.
• On Wednesday, December 11th, Saiyed Atiq Raza sold 2,400 shares of Arteris stock. The stock was sold at an average price of $10.01, for a total value of $24,024.00.

Arteris Price Performance

Shares of NASDAQ AIP remained flat at $11.25 during midday trading on Wednesday. The stock had a trading volume of 325,673 shares, compared to its average volume of 667,995. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.16 and a quick ratio of 1.16. The firm has a market cap of $451.99 million, a PE ratio of -11.72 and a beta of 1.17. The firm has a 50-day moving average price of $9.08 and a 200 day moving average price of $8.11. Arteris, Inc. has a 12-month low of $4.83 and a 12-month high of $12.64.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the business. US Bancorp DE bought a new stake in shares of Arteris during the 3rd quarter worth $34,000. The Manufacturers Life Insurance Company purchased a new stake in Arteris during the second quarter worth about $86,000. Algert Global LLC purchased a new stake in Arteris during the second quarter worth about $115,000. MetLife Investment Management LLC raised its position in Arteris by 129.1% in the third quarter. MetLife Investment Management LLC now owns 16,951 shares of the company’s stock worth $131,000 after acquiring an additional 9,551 shares during the period. Finally, Dynamic Technology Lab Private Ltd purchased a new position in Arteris in the third quarter valued at about $226,000. Hedge funds and other institutional investors own 64.36% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, Rosenblatt Securities reaffirmed a “buy” rating and set a $15.00 price objective on shares of Arteris in a report on Wednesday, November 6th.

About Arteris

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.